Ligand Pharmaceuticals (LGND)
LGND · BiotechSign PipelinePipeline Overview
- Therapeutic Focus
- Royalties/Licensingsrc
Signal Snapshot
0
Clinical Trials (ClinicalTrials.gov aggregate)
0
Catalyst Records
5
Publications on Record
ClinicalTrials.gov aggregate as of 2026-09-29. Source
Recent Publications
- Design, synthesis and biological evaluation of a series of new, potent FLT3 PROTAC degraders with rigid linkers. — Bioorg Med Chem (2026) PMID 42772077
- Design and syntheses of 4-aminoquinoline-thiazolidinone hybrids as anti-protozoal agents. — Front Chem (2026) PMID 42769294
5 total publications tracked — view all on BiotechSign
Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Ligand Pharmaceuticals.
Full LGND Data Sign Up FreePrimary Sources
This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.